Advaxis (ADXS) Misses Q2 EPS by 29c

Advaxis (OTC: ADXS) reported Q2 EPS of ($1.82), $0.29 worse than the analyst estimate of ($1.53).

For earnings history and earnings-related data on Advaxis (ADXS) click here.

You May Also Be Interested In

• AI and earnings keep driving markets as focus shifts to Trump-Xi summit
• UBS Reiterates Buy Rating on Option Care Health (OPCH) Following Check-in Call Ahead of Quiet Period
• AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c